Doxorubicin

NLR family pyrin domain containing 3 ; Homo sapiens







10 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34747550 The modulation of SIRT1 and SIRT3 by natural compounds as a therapeutic target in doxorubicin-induced cardiotoxicity: A review. 2022 Jan 1
2 35221708 CASPorter: A Novel Inducible Human CASP1/NALP3/ASC Inflammasome Biosensor. 2022 11
3 35551917 Resolvin E1 attenuates doxorubicin-induced endothelial senescence by modulating NLRP3 inflammasome activation. 2022 Jul 4
4 32852568 The beneficial effects of reducing NLRP3 inflammasome activation in the cardiotoxicity and the anti-cancer effects of doxorubicin. 2021 Jan 6
5 34257710 BMP-2 alleviates heart failure with type 2 diabetes mellitus and doxorubicin-induced AC16 cell injury by inhibiting NLRP3 inflammasome-mediated pyroptosis. 2021 Aug 1
6 34350498 Inflammation suppression in doxorubicin-induced cardiotoxicity: natural compounds as therapeutic options. 2021 Oct 1
7 31746354 Honokiol antagonizes doxorubicin‑induced cardiomyocyte senescence by inhibiting TXNIP‑mediated NLRP3 inflammasome activation. 2020 Jan 3
8 32968631 Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner. 2020 Aug 2
9 31445005 Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3. 2019 Nov 4
10 25046000 Production of IL-1β by bone marrow-derived macrophages in response to chemotherapeutic drugs: synergistic effects of doxorubicin and vincristine. 2014 Oct 1